These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 28342863)
21. Predictive value of plasma miRNA-718 for esophageal squamous cell carcinoma. Sun L; Dong S; Dong C; Sun K; Meng W; Lv P; Yin H; Ming L; He F Cancer Biomark; 2016; 16(2):265-73. PubMed ID: 26756617 [TBL] [Abstract][Full Text] [Related]
22. Novel circulating peptide biomarkers for esophageal squamous cell carcinoma revealed by a magnetic bead-based MALDI-TOFMS assay. Jia K; Li W; Wang F; Qu H; Qiao Y; Zhou L; Sun Y; Ma Q; Zhao X Oncotarget; 2016 Apr; 7(17):23569-80. PubMed ID: 26993605 [TBL] [Abstract][Full Text] [Related]
23. Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma. Wang W; He X; Zheng Z; Ma X; Hu X; Wu D; Wang M Mol Cancer; 2017 Apr; 16(1):75. PubMed ID: 28376832 [TBL] [Abstract][Full Text] [Related]
24. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma. Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466 [TBL] [Abstract][Full Text] [Related]
25. MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma. Sun J; Song K; Feng X; Gao S Biochem Biophys Res Commun; 2016 Apr; 473(2):363-9. PubMed ID: 26777997 [TBL] [Abstract][Full Text] [Related]
26. ORAOV1 overexpression in esophageal squamous cell carcinoma and esophageal dysplasia: a possible biomarker of progression and poor prognosis in esophageal carcinoma. Li M; Cui X; Shen Y; Dong H; Liang W; Chen Y; Hu J; Li S; Kong J; Li H; Zhao J; Li F Hum Pathol; 2015 May; 46(5):707-15. PubMed ID: 25732110 [TBL] [Abstract][Full Text] [Related]
27. Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma. Xu YW; Peng YH; Ran LQ; Zhai TT; Guo HP; Qiu SQ; Chen HL; Wu ZY; Li EM; Xie JJ Clin Transl Oncol; 2017 Jul; 19(7):898-906. PubMed ID: 28181176 [TBL] [Abstract][Full Text] [Related]
28. Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE. Jing R; Chen W; Wang H; Ju S; Cong H; Sun B; Jin Q; Chu S; Xu L; Cui M Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G719-29. PubMed ID: 26316588 [TBL] [Abstract][Full Text] [Related]
29. Upregulation of uc.189 in patients with esophageal squamous cell carcinoma and its clinicopathologic value. Guo Y; Wang C; Miao X; Chen S; Qian Y; Li G; Jiang Y Pathol Res Pract; 2017 Nov; 213(11):1400-1403. PubMed ID: 28941722 [TBL] [Abstract][Full Text] [Related]
30. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis. Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434 [TBL] [Abstract][Full Text] [Related]
31. Activation of choline kinase drives aberrant choline metabolism in esophageal squamous cell carcinomas. Ma W; Wang S; Zhang T; Zhang EY; Zhou L; Hu C; Yu JJ; Xu G J Pharm Biomed Anal; 2018 Jun; 155():148-156. PubMed ID: 29631075 [TBL] [Abstract][Full Text] [Related]
32. Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients. Yu W; Yang X; Chu L; Zhao K; Chen H; Xiang J; Zhang Y; Li H; Zhao W; Sun M; Wei Q; Fu X; Xie C; Zhu Z Pathol Res Pract; 2018 Jul; 214(7):1017-1023. PubMed ID: 29729836 [TBL] [Abstract][Full Text] [Related]
33. The association between serum Dickkopf-1 levels and esophageal squamous cell carcinoma. Begenik H; Kemik AS; Emre H; Dulger AC; Demirkiran D; Ebinc S; Kemik O Hum Exp Toxicol; 2014 Aug; 33(8):785-8. PubMed ID: 24220876 [TBL] [Abstract][Full Text] [Related]
34. Downregulation of miR-138 predicts poor prognosis in patients with esophageal squamous cell carcinoma. Zheng S; Zhang X; Wang X; Li J Cancer Biomark; 2017 Jul; 20(1):49-54. PubMed ID: 28759955 [TBL] [Abstract][Full Text] [Related]
35. [Clinical significance of serum high-mobility group box 1 detection in esophageal squamous cell carcinoma]. Chen CG; Cui L; Tang P; Yu ZT Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):838-41. PubMed ID: 24061989 [TBL] [Abstract][Full Text] [Related]
36. Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging. Xu J; Chen Y; Zhang R; He J; Song Y; Wang J; Wang H; Wang L; Zhan Q; Abliz Z Sci Rep; 2016 Oct; 6():35010. PubMed ID: 27725730 [TBL] [Abstract][Full Text] [Related]
37. Down-regulation of lncRNA MIR31HG correlated with aggressive clinicopathological features and unfavorable prognosis in esophageal squamous cell carcinoma. Ren ZP; Chu XY; Xue ZQ; Zhang LB; Wen JX; Deng JQ; Hou XB Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3866-3870. PubMed ID: 28975978 [TBL] [Abstract][Full Text] [Related]
38. Overexpression of PLCE1 in Kazakh esophageal squamous cell carcinoma: implications in cancer metastasis and aggressiveness. Chen YZ; Cui XB; Hu JM; Zhang WJ; Li SG; Yang L; Shen XH; Liu CX; Pan QF; Yu SY; Yuan XL; Yang L; Gu WY; Chen JZ; Wang LD; Li F APMIS; 2013 Oct; 121(10):908-18. PubMed ID: 23659763 [TBL] [Abstract][Full Text] [Related]
39. Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Chen FJ; Sun M; Li SQ; Wu QQ; Ji L; Liu ZL; Zhou GZ; Cao G; Jin L; Xie HW; Wang CM; Lv J; De W; Wu M; Cao XF Mol Carcinog; 2013 Nov; 52(11):908-15. PubMed ID: 24151120 [TBL] [Abstract][Full Text] [Related]
40. Identification of extracellular matrix protein 1 as a potential plasma biomarker of ESCC by proteomic analysis using iTRAQ and 2D-LC-MS/MS. Wang X; Peng Y; Xie M; Gao Z; Yin L; Pu Y; Liu R Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28493612 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]